KRAS — 487 ClinVar variants
All ClinVar germline KRAS variants across every classification, each assembled from ClinVar, gnomAD, AlphaMissense, conservation and more. 108 flagged for review →
33 Pathogenic · 17 Pathogenic/Likely pathogenic · 38 Likely pathogenic · 22 Conflicting · 31 Benign · 12 Benign/Likely benign · 146 Likely benign · 188 Uncertain significance
Full KRAS gene report on Sugi Atlas → Gene function, pathways, protein structure, constraint & interactions⚑ Evidence disagreements 108
Variants where the independent computational evidence doesn't line up with the clinical picture — a QC signal for a second look, not a reclassification.
Predictors vs ClinVar 1
ClinVar calls these pathogenic, but the computational predictors lean tolerated — the highest-value review flag.
-
KRAS p.Lys147Arg
Pathogenic
Single submitter
Noonan syndrome 3
Predictors agree, ClinVar conflicts 9
ClinVar submitters conflict, but the independent predictors unanimously agree — a QC review flag, not a reclassification.
- KRAS c.451-5535A>C Conflicting Single submitter
-
KRAS c.451-5604T>C
Conflicting
Single submitter
KRAS-related disorder
-
KRAS p.Ala146Ser
Conflicting
Single submitter
RASopathy
-
KRAS p.Ala146Thr
Conflicting
Single submitter
vascular malformation
-
KRAS p.Gln61His
Conflicting
Single submitter
colorectal cancer
- KRAS p.Gly60Asp Conflicting Single submitter
- KRAS p.Leu23Arg Conflicting Single submitter
-
KRAS p.Thr74Pro
Conflicting
Single submitter
non-immune hydrops fetalis
-
KRAS p.Tyr32Cys
Conflicting
Single submitter
Noonan syndrome 3
Predicted LoF vs a conflicting call 1
ClinVar submitters conflict, and it's a predicted loss-of-function change in a gene where LoF causes disease — flagged for review, not resolved (verify NMD-escape for C-terminal truncations). Non-missense.
-
KRAS p.Arg164Ter
Conflicting
Single submitter
exocrine pancreatic carcinoma
Predictors lean, ClinVar uncertain 64
ClinVar classifies these uncertain (VUS), but the independent predictors unanimously lean one way — a triage signal for review, not a reclassification.
-
KRAS c.451-5538A>G
Uncertain significance
Multiple submitters
KRAS-related disorder
- KRAS c.451-5622G>A Uncertain significance Multiple submitters
-
KRAS p.Ala130Val
Uncertain significance
Multiple submitters
RASopathy
-
KRAS p.Asn26Tyr
Uncertain significance
Multiple submitters
RASopathy
-
KRAS p.Asp33Gly
Uncertain significance
Multiple submitters
RASopathy
-
KRAS p.Cys118Arg
Uncertain significance
Multiple submitters
RASopathy
-
KRAS p.Ile84Val
Uncertain significance
Multiple submitters
RASopathy
-
KRAS p.Ser122Cys
Uncertain significance
Multiple submitters
RASopathy
-
KRAS c.451-5588T>C
Uncertain significance
Single submitter
RASopathy
- KRAS p.Ala130Pro Uncertain significance Single submitter
- KRAS p.Ala134Thr Uncertain significance Single submitter
-
KRAS p.Ala59Glu
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Ala66Ser
Uncertain significance
Single submitter
Inborn genetic diseases
-
KRAS p.Arg123Ile
Uncertain significance
Single submitter
RASopathy
- KRAS p.Arg41Gly Uncertain significance Single submitter
-
KRAS p.Asn26His
Uncertain significance
Single submitter
Noonan syndrome 3
-
KRAS p.Asp154Gly
Uncertain significance
Single submitter
Noonan syndrome 3
- KRAS p.Asp154Val Uncertain significance Single submitter
-
KRAS p.Asp38Asn
Uncertain significance
Single submitter
RASopathy
- KRAS p.Asp47Gly Uncertain significance Single submitter
-
KRAS p.Asp92Asn
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Cys51Gly
Uncertain significance
Single submitter
RASopathy
- KRAS p.Cys51Ser Uncertain significance Single submitter
-
KRAS p.Cys51Trp
Uncertain significance
Single submitter
Cardiovascular phenotype
-
KRAS p.Gln61Pro
Uncertain significance
Single submitter
RASopathy
- KRAS p.Glu63Asp Uncertain significance Single submitter
- KRAS p.Gly77Ser Uncertain significance Single submitter
-
KRAS p.Gly77Val
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Ile187Thr
Uncertain significance
Single submitter
Cardiovascular phenotype
-
KRAS p.Ile187Val
Uncertain significance
Single submitter
autoimmune lymphoproliferative syndrome type 4
- KRAS p.Ile36Val Uncertain significance Single submitter
-
KRAS p.Ile46Met
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Leu52Phe
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Met111Thr
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Pro140Ser
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Ser17Thr
Uncertain significance
Single submitter
vascular malformation
-
KRAS p.Thr148Arg
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Thr20Ala
Uncertain significance
Single submitter
cardiofaciocutaneous syndrome 2
-
KRAS p.Tyr40Cys
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Tyr64Asn
Uncertain significance
Single submitter
Inborn genetic diseases
-
KRAS p.Tyr64Ser
Uncertain significance
Single submitter
Inborn genetic diseases
-
KRAS p.Val103Phe
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Val109Ala
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Val109Glu
Uncertain significance
Single submitter
Cardiovascular phenotype
-
KRAS p.Val29Met
Uncertain significance
Single submitter
Noonan syndrome 3
-
KRAS p.Val81Ala
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Val9Ala
Uncertain significance
Single submitter
Cardiovascular phenotype
-
KRAS p.Asn26Thr
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.Gln22Pro
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
- KRAS p.Gln25Arg Uncertain significance No assertion criteria
-
KRAS p.Gln25Leu
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.Glu63Lys
Uncertain significance
No assertion criteria
teratoma
-
KRAS p.Gly15Cys
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.His27Arg
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.His27Leu
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.Ile21Lys
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.Ile36Lys
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.Ile55Ser
Uncertain significance
No assertion criteria
Noonan syndrome
-
KRAS p.Leu6Phe
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.Phe28Leu
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.Ser17Ile
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.Tyr32Ser
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.Tyr4Asn
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
- KRAS p.Val7Met Uncertain significance No assertion criteria
Predictors split 33
The independent predictors disagree with each other — read with care.
- KRAS p.Ala134Gly Uncertain significance Multiple submitters
-
KRAS p.Asp108Tyr
Uncertain significance
Multiple submitters
RASopathy
-
KRAS p.His95Asn
Uncertain significance
Multiple submitters
RASopathy
-
KRAS p.Met111Val
Uncertain significance
Multiple submitters
cardiofaciocutaneous syndrome 2
-
KRAS p.Ala130Ser
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Asp108Glu
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Asp132Glu
Uncertain significance
Single submitter
RASopathy
- KRAS p.Gly138Ala Uncertain significance Single submitter
- KRAS p.His95Tyr Uncertain significance Single submitter
- KRAS p.Ile188Lys Uncertain significance Single submitter
-
KRAS p.Ile46Val
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Leu6Val
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Phe141Tyr
Uncertain significance
Single submitter
hereditary breast carcinoma
-
KRAS p.Phe90Tyr
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Ser136Asn
Conflicting
Single submitter
Noonan syndrome 3
-
KRAS p.Ser65Thr
Uncertain significance
Single submitter
Cardiovascular phenotype
- KRAS p.Thr124Ile Uncertain significance Single submitter
- KRAS p.Thr127Arg Uncertain significance Single submitter
-
KRAS p.Thr2Pro
Uncertain significance
Single submitter
Cardiovascular phenotype
-
KRAS p.Thr50Ala
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Thr50Ile
Conflicting
Single submitter
RASopathy
- KRAS p.Thr50Pro Likely pathogenic Single submitter
- KRAS p.Thr50Ser Uncertain significance Single submitter
-
KRAS p.Thr87Ala
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Val109Ile
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Val125Ile
Uncertain significance
Single submitter
RASopathy
-
KRAS p.Ala11Ser
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.Arg167Thr
Likely benign
No assertion criteria
Noonan syndrome
-
KRAS p.Arg97Lys
Likely pathogenic
No assertion criteria
non-small cell lung carcinoma
-
KRAS p.Asp30Glu
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.Thr2Ser
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
-
KRAS p.Tyr4Phe
Uncertain significance
No assertion criteria
prostate cancer, hereditary, 1
- KRAS p.Val8Ile Uncertain significance No assertion criteria
All KRAS variants
Pathogenic 33
- p.Asp153Val Expert panel RASopathy
- p.Gln22Arg Expert panel RASopathy
- p.Gly60Arg Expert panel cardiofaciocutaneous syndrome
- p.Lys5Asn Expert panel RASopathy
- p.Pro34Leu Expert panel Noonan syndrome
- p.Thr58Ile Expert panel Noonan syndrome
- p.Val14Ile Expert panel RASopathy
- c.*22C>G Multiple submitters KRAS-related disorder
- p.Gly12Ser Multiple submitters vascular malformation
- p.Gly12Val Multiple submitters RASopathy
- p.Gly13Asp Multiple submitters Noonan syndrome and Noonan-related syndrome
- p.Gly60Ser Multiple submitters Fetal anomalies with a likely genetic cause
- p.Phe156Ile Multiple submitters Noonan syndrome
- c.*11G>A Single submitter
- p.Ala11delinsGlyPro Single submitter
- p.Ala18Val Single submitter Noonan syndrome 3
- p.Ala66_Met67insAspLeuLeu Single submitter Capillary Telangiectasia, Brain
- p.Asn116His Single submitter
- p.Gln22Glu Single submitter RASopathy
- p.Gln61Arg Single submitter vascular malformation
- p.Gln61Leu Single submitter non-small cell lung carcinoma
- p.Gln61Lys Single submitter non-small cell lung carcinoma
- p.Gly13Arg Single submitter non-small cell lung carcinoma
- p.Gly13Val Single submitter non-small cell lung carcinoma
- p.Leu19Phe Single submitter RASopathy
- p.Lys147Arg Single submitter Noonan syndrome 3 ⚠
- p.Met72Leu Single submitter RASopathy
- p.Phe156Ser Single submitter RASopathy
- p.Tyr64_Ser65insArgAlaMetArgAspGlnTyr Single submitter Noonan syndrome 3
- c.*9T>G No assertion criteria Noonan syndrome 3
- p.Ala59Thr No assertion criteria Bladder cancer, transitional cell, somatic
- p.Gly10dup No assertion criteria acute myeloid leukemia
- p.Tyr71His No assertion criteria cardiofaciocutaneous syndrome 2
Pathogenic/Likely pathogenic 17
- c.451-5642A>T Multiple submitters Noonan syndrome 3
- p.Ala146Pro Multiple submitters RASopathy
- p.Ala146Val Multiple submitters familial pancreatic carcinoma
- p.Ala59Ser Multiple submitters
- p.Arg68Ser Multiple submitters RASopathy
- p.Asp153Gly Multiple submitters RASopathy
- p.Gln22Lys Multiple submitters vascular malformation
- p.Gly12Ala Multiple submitters lung cancer
- p.Gly12Arg Multiple submitters RASopathy
- p.Gly12Asp Multiple submitters gastric cancer
- p.Gly13Cys Multiple submitters KRAS-related disorder
- p.Gly60Val Multiple submitters RASopathy
- p.Ile36Met Multiple submitters Cardiovascular phenotype
- p.Lys147Glu Multiple submitters cardiofaciocutaneous syndrome 2
- p.Lys5Glu Multiple submitters KRAS-related disorder
- p.Phe156Val Multiple submitters Noonan syndrome
- p.Pro34Arg Multiple submitters acute myeloid leukemia
Likely pathogenic 38
- p.Ser65Ile Expert panel RASopathy
- p.Asp119Asn Multiple submitters acute myeloid leukemia
- p.Tyr71Asp Multiple submitters cardiofaciocutaneous syndrome
- p.Ala59Leu Single submitter cardiofaciocutaneous syndrome 2
- p.Ala66_Met67insGlyGlnGluGluTyrSerAla Single submitter vascular malformation
- p.Ala66_Thr74dup Single submitter Venous malformation
- p.Arg68Gly Single submitter RASopathy
- p.Arg68Trp Single submitter Noonan syndrome 3
- p.Arg73_Thr74insSerAlaMetArgAspGlnTyrMetArg Single submitter vascular malformation
- p.Asn116Ser Single submitter Noonan syndrome 1
- p.Asp154del Single submitter Fetal anomalies with a likely genetic cause
- p.Asp69_Gln70insGluTyrSerAlaMetArgAsp Single submitter vascular malformation
- p.Gln22Leu Single submitter
- p.Gly12Cys Single submitter RASopathy
- p.Gly13= Single submitter non-small cell lung carcinoma
- p.Gly15Val Single submitter
- p.Gly77Cys Single submitter Noonan syndrome 3
- p.Leu53Trp Single submitter Noonan syndrome 3
- p.Lys117Arg Single submitter linear nevus sebaceous syndrome
- p.Lys117Asn Single submitter Mosaic KRAS-related syndrome
- p.Lys117Thr Single submitter Cardiovascular phenotype
- p.Lys147Asn Single submitter RASopathy
- p.Lys147Met Single submitter Noonan syndrome 3
- p.Lys5Gln Single submitter RASopathy
- p.Met72_Arg73insLeuAspThrAlaGlyGlnGluGluTyrSerAlaMetArgAspGlnTyrMet Single submitter vascular malformation
- p.Pro34Gln Single submitter KRAS-related disorder
- p.Thr20Met Single submitter
- p.Thr50Pro Single submitter ⚠
- p.Thr58_Tyr71dup Single submitter
- p.Tyr64_Ala66delinsSerSerSer Single submitter Cardiovascular phenotype
- p.Tyr71_Met72insIleGluGluTyrSerAlaMetArgAspGlnTyr Single submitter vascular malformation
- p.Val152Phe Single submitter Noonan syndrome
- p.Val7Glu Single submitter RASopathy
- p.Arg149Ter No assertion criteria thyroid cancer, nonmedullary, 1
- p.Arg68del No assertion criteria Noonan syndrome 3
- p.Arg97Lys No assertion criteria non-small cell lung carcinoma ⚠
- p.Glu153Ala No assertion criteria Noonan syndrome
- p.Thr74Ile No assertion criteria Noonan syndrome
Conflicting classifications of pathogenicity 22
- c.111+8T>G Single submitter RASopathy
- c.112-5C>T Single submitter cardiofaciocutaneous syndrome 2
- c.451-5535A>C Single submitter ⚠
- c.451-5560T>A Single submitter cardiofaciocutaneous syndrome
- c.451-5604T>C Single submitter KRAS-related disorder ⚠
- c.*101_*106del Single submitter Noonan syndrome
- c.*44C>T Single submitter Noonan syndrome 3
- p.Ala146Ser Single submitter RASopathy ⚠
- p.Ala146Thr Single submitter vascular malformation ⚠
- p.Ala83= Single submitter Cardiovascular phenotype
- p.Arg164Ter Single submitter exocrine pancreatic carcinoma ⚠
- p.Gln61His Single submitter colorectal cancer ⚠
- p.Glu31= Single submitter Cardiovascular phenotype
- p.Glu63del Single submitter autoimmune lymphoproliferative syndrome type 4
- p.Glu76= Single submitter RASopathy
- p.Gly60Asp Single submitter ⚠
- p.Leu23Arg Single submitter ⚠
- p.Leu56= Single submitter Cardiovascular phenotype
- p.Ser136Asn Single submitter Noonan syndrome 3 ⚠
- p.Thr50Ile Single submitter RASopathy ⚠
- p.Thr74Pro Single submitter non-immune hydrops fetalis ⚠
- p.Tyr32Cys Single submitter Noonan syndrome 3 ⚠
Benign 31
- p.Asp173= Expert panel RASopathy
- c.290+74T>G Multiple submitters
- c.290+97A>C Multiple submitters
- c.290+97A>T Multiple submitters
- c.291-162A>C Multiple submitters
- c.450+92A>G Multiple submitters
- c.451-5617= Multiple submitters Cardiovascular phenotype
- c.451-9G>A Multiple submitters RASopathy
- c.111+14del Single submitter RASopathy
- c.111+190A>T Single submitter
- c.291-10dup Single submitter RASopathy
- c.4+287A>G Single submitter
- c.450+298_450+322del Single submitter
- c.450+298T>A Single submitter
- c.450+300_450+322del Single submitter
- c.450+304_450+322del Single submitter
- c.450+306_450+322del Single submitter
- c.450+308_450+322del Single submitter
- c.450+40A>G Single submitter
- c.451-5617A>G Single submitter
- c.-11-273A>G Single submitter
- c.-12+162G>C Single submitter
- c.-178_-170del Single submitter
- c.-190C>T Single submitter
- c.*1634A>G Single submitter
- c.*1758_*1759del Single submitter
- c.*3672C>G Single submitter
- c.*4036A>G Single submitter
- c.*4187del Single submitter
- c.*4619T>C Single submitter
- c.*37A>G No assertion criteria
Benign/Likely benign 12
- c.112-12C>T Multiple submitters RASopathy
- c.4+5G>A Multiple submitters hereditary breast carcinoma
- c.451-5565G>A Multiple submitters Cardiovascular phenotype
- c.5-18A>G Multiple submitters hereditary breast carcinoma
- c.-27C>T Multiple submitters
- c.-48G>A Multiple submitters
- c.*2626T>G Multiple submitters Noonan syndrome and Noonan-related syndrome
- c.*298T>G Multiple submitters Noonan syndrome and Noonan-related syndrome
- c.*4200T>A Multiple submitters Noonan syndrome and Noonan-related syndrome
- c.*633T>C Multiple submitters Noonan syndrome and Noonan-related syndrome
- p.Ala66= Multiple submitters RASopathy
- p.Lys88= Multiple submitters RASopathy
Likely benign 146
- c.451-14T>C Expert panel RASopathy
- p.Asp30= Expert panel RASopathy
- p.Val8= Expert panel RASopathy
- c.111+46T>G Multiple submitters
- c.112-10C>T Multiple submitters RASopathy
- c.112-9C>T Multiple submitters RASopathy
- c.291-10del Multiple submitters RASopathy
- c.450+16A>G Multiple submitters RASopathy
- c.451-10T>C Multiple submitters RASopathy
- c.451-5652C>T Multiple submitters autoimmune lymphoproliferative syndrome type 4
- c.5-11A>G Multiple submitters RASopathy
- c.-9C>T Multiple submitters
- c.*103A>G Multiple submitters Cardiovascular phenotype
- c.*16T>C Multiple submitters Cardiovascular phenotype
- c.*671C>T Multiple submitters Noonan syndrome and Noonan-related syndrome
- p.Ala146= Multiple submitters Cardiovascular phenotype
- p.Ala155= Multiple submitters Cardiovascular phenotype
- p.Ala18= Multiple submitters RASopathy
- p.Arg161= Multiple submitters Cardiovascular phenotype
- p.Asp47= Multiple submitters RASopathy
- p.Gln22= Multiple submitters RASopathy
- p.Glu62= Multiple submitters RASopathy
- p.Gly151= Multiple submitters RASopathy
- p.His166= Multiple submitters Cardiovascular phenotype
- p.Ile139= Multiple submitters RASopathy
- p.Ile142= Multiple submitters Cardiovascular phenotype
- p.Leu120= Multiple submitters Cardiovascular phenotype
- p.Leu52= Multiple submitters Cardiovascular phenotype
- p.Lys5= Multiple submitters RASopathy
- p.Ser145= Multiple submitters Cardiovascular phenotype
- p.Thr20= Multiple submitters Cardiovascular phenotype
- p.Thr35= Multiple submitters RASopathy
- p.Thr50= Multiple submitters Cardiovascular phenotype
- p.Thr74= Multiple submitters RASopathy
- p.Thr87= Multiple submitters RASopathy
- p.Tyr137= Multiple submitters RASopathy
- p.Val112= Multiple submitters Cardiovascular phenotype
- p.Val125= Multiple submitters Cardiovascular phenotype
- p.Val152= Multiple submitters RASopathy
- c.111+10G>A Single submitter RASopathy
- c.111+16A>G Single submitter RASopathy
- c.111+239A>G Single submitter
- c.111+9_111+19del Single submitter RASopathy
- c.112-10_112-9insGAAT Single submitter RASopathy
- c.112-10C>G Single submitter RASopathy
- c.112-12C>G Single submitter RASopathy
- c.112-14T>G Single submitter RASopathy
- c.112-20C>A Single submitter RASopathy
- c.112-8C>T Single submitter RASopathy
- c.112-9C>G Single submitter RASopathy
- c.290+11A>G Single submitter RASopathy
- c.290+14G>C Single submitter RASopathy
- c.290+18A>G Single submitter RASopathy
- c.290+7T>A Single submitter RASopathy
- c.291-128T>G Single submitter
- c.291-18C>T Single submitter RASopathy
- c.291-23TA[3] Single submitter RASopathy
- c.291-311A>G Single submitter
- c.291-6del Single submitter RASopathy
- c.291-7T>G Single submitter RASopathy
- c.450+11C>G Single submitter
- c.450+13G>A Single submitter
- c.450+20A>G Single submitter RASopathy
- c.450+296T>A Single submitter
- c.450+304T>A Single submitter
- c.450+7_450+8del Single submitter RASopathy
- c.451-12T>G Single submitter RASopathy
- c.451-13T>C Single submitter RASopathy
- c.451-224T>A Single submitter
- c.451-5327G>A Single submitter
- c.451-5542C>T Single submitter
- c.451-5575A>G Single submitter
- c.451-5604T>A Single submitter
- c.5-240G>A Single submitter
- c.-11-324T>G Single submitter
- c.-12+116G>T Single submitter
- c.-163AGC[3] Single submitter
- c.-167A>G Single submitter
- c.-44A>G Single submitter
- c.-54C>T Single submitter
- c.*1094G>T Single submitter
- c.*1204A>G Single submitter
- c.*134C>T Single submitter
- c.*1708T>C Single submitter
- c.*1759A>G Single submitter
- c.*1776C>T Single submitter
- c.*1826C>G Single submitter
- c.*3009A>G Single submitter
- c.*3498C>T Single submitter
- c.*3522T>A Single submitter
- c.*3623T>A Single submitter
- c.*3766A>G Single submitter
- c.*3881A>C Single submitter
- c.*3907A>G Single submitter
- c.*4022A>C Single submitter
- c.*4059A>G Single submitter
- c.*4432A>G Single submitter
- c.*4549G>C Single submitter
- p.Ala134= Single submitter Cardiovascular phenotype
- p.Arg73= Single submitter Cardiovascular phenotype
- p.Asn116= Single submitter Cardiovascular phenotype
- p.Asn85= Single submitter RASopathy
- p.Asp105= Single submitter Cardiovascular phenotype
- p.Asp126= Single submitter Cardiovascular phenotype
- p.Asp132= Single submitter Cardiovascular phenotype
- p.Asp57= Single submitter RASopathy
- p.Cys51= Single submitter Cardiovascular phenotype
- p.Gln129= Single submitter Cardiovascular phenotype
- p.Gln25= Single submitter prostate cancer, hereditary, 1
- p.Gln99= Single submitter RASopathy
- p.Gly12= Single submitter Cardiovascular phenotype
- p.Gly48= Single submitter Cardiovascular phenotype
- p.His27= Single submitter Cardiovascular phenotype
- p.Ile100= Single submitter Cardiovascular phenotype
- p.Leu113= Single submitter Cardiovascular phenotype
- p.Leu159= Single submitter Cardiovascular phenotype
- p.Leu23= Single submitter Cardiovascular phenotype
- p.Lys104= Single submitter Cardiovascular phenotype
- p.Lys117= Single submitter Cardiovascular phenotype
- p.Lys169= Single submitter RASopathy
- p.Lys178= Single submitter RASopathy
- p.Lys180del Single submitter RASopathy
- p.Lys182= Single submitter Cardiovascular phenotype
- p.Lys42= Single submitter Cardiovascular phenotype
- p.Phe156= Single submitter RASopathy
- p.Phe78= Single submitter Cardiovascular phenotype
- p.Pro121= Single submitter Cardiovascular phenotype
- p.Pro34= Single submitter Cardiovascular phenotype
- p.Ser122= Single submitter Cardiovascular phenotype
- p.Ser171= Single submitter RASopathy
- p.Thr124= Single submitter RASopathy
- p.Thr127= Single submitter Cardiovascular phenotype
- p.Thr144= Single submitter RASopathy
- p.Thr148= Single submitter Cardiovascular phenotype
- p.Thr158= Single submitter Cardiovascular phenotype
- p.Tyr40= Single submitter RASopathy
- p.Val160= Single submitter Cardiovascular phenotype
- p.Val186= Single submitter Cardiovascular phenotype
- p.Val44= Single submitter RASopathy
- p.Val45= Single submitter Cardiovascular phenotype
- p.Val7= Single submitter RASopathy
- p.Val81= Single submitter Cardiovascular phenotype
- c.-158C>G No assertion criteria KRAS-related disorder
- c.-167A>C No assertion criteria KRAS-related disorder
- c.-169_-149del No assertion criteria KRAS-related disorder
- p.Arg167Thr No assertion criteria Noonan syndrome ⚠
Uncertain significance 188
- p.Met170Leu Expert panel RASopathy
- c.450+5G>A Multiple submitters linear nevus sebaceous syndrome
- c.451-5538A>G Multiple submitters KRAS-related disorder ⚠
- c.451-5622G>A Multiple submitters ⚠
- p.Ala130Ile Multiple submitters RASopathy
- p.Ala130Val Multiple submitters RASopathy ⚠
- p.Ala134Gly Multiple submitters ⚠
- p.Arg161Ter Multiple submitters RASopathy
- p.Arg164Gln Multiple submitters RASopathy
- p.Asn26Tyr Multiple submitters RASopathy ⚠
- p.Asp108Tyr Multiple submitters RASopathy ⚠
- p.Asp33Gly Multiple submitters RASopathy ⚠
- p.Cys118Arg Multiple submitters RASopathy ⚠
- p.His95Asn Multiple submitters RASopathy ⚠
- p.Ile163Val Multiple submitters RASopathy
- p.Ile84Val Multiple submitters RASopathy ⚠
- p.Lys184fs Multiple submitters RASopathy
- p.Met111Val Multiple submitters cardiofaciocutaneous syndrome 2 ⚠
- p.Ser122Cys Multiple submitters RASopathy ⚠
- p.Tyr157Cys Multiple submitters RASopathy
- c.291-5C>G Single submitter
- c.450+3A>G Single submitter RASopathy
- c.451-3C>T Single submitter RASopathy
- c.451-5518T>C Single submitter
- c.451-5588T>C Single submitter RASopathy ⚠
- c.451-6_452delinsCACTTGTTTTACACACA Single submitter
- c.451-6T>C Single submitter cardiofaciocutaneous syndrome 2
- c.-14G>C Single submitter Noonan syndrome and Noonan-related syndrome
- c.-167_-153dup Single submitter Noonan syndrome and Noonan-related syndrome
- c.-178C>A Single submitter
- c.-3A>G Single submitter
- c.*110G>T Single submitter
- c.*4+1G>A Single submitter
- c.*525T>C Single submitter Noonan syndrome and Noonan-related syndrome
- p.Ala130Pro Single submitter ⚠
- p.Ala130Ser Single submitter RASopathy ⚠
- p.Ala134Thr Single submitter ⚠
- p.Ala59Glu Single submitter RASopathy ⚠
- p.Ala66Ser Single submitter Inborn genetic diseases ⚠
- p.Arg123Ile Single submitter RASopathy ⚠
- p.Arg161Gln Single submitter RASopathy
- p.Arg41Gly Single submitter ⚠
- p.Asn26His Single submitter Noonan syndrome 3 ⚠
- p.Asp108Glu Single submitter RASopathy ⚠
- p.Asp132Glu Single submitter RASopathy ⚠
- p.Asp154Gly Single submitter Noonan syndrome 3 ⚠
- p.Asp154Val Single submitter ⚠
- p.Asp38Asn Single submitter RASopathy ⚠
- p.Asp47Gly Single submitter ⚠
- p.Asp92Asn Single submitter RASopathy ⚠
- p.Cys51Gly Single submitter RASopathy ⚠
- p.Cys51Ser Single submitter ⚠
- p.Cys51Trp Single submitter Cardiovascular phenotype ⚠
- p.Gln61Pro Single submitter RASopathy ⚠
- p.Glu168fs Single submitter RASopathy
- p.Glu63Asp Single submitter ⚠
- p.Gly138Ala Single submitter ⚠
- p.Gly174Ser Single submitter RASopathy
- p.Gly75= Single submitter RASopathy
- p.Gly77Ser Single submitter ⚠
- p.Gly77Val Single submitter RASopathy ⚠
- p.His95Tyr Single submitter ⚠
- p.Ile163Thr Single submitter
- p.Ile187Thr Single submitter Cardiovascular phenotype ⚠
- p.Ile187Val Single submitter autoimmune lymphoproliferative syndrome type 4 ⚠
- p.Ile188Lys Single submitter ⚠
- p.Ile36Val Single submitter ⚠
- p.Ile46Met Single submitter RASopathy ⚠
- p.Ile46Val Single submitter RASopathy ⚠
- p.Leu159fs Single submitter Noonan syndrome 3
- p.Leu52Phe Single submitter RASopathy ⚠
- p.Leu6Val Single submitter RASopathy ⚠
- p.Lys167del Single submitter RASopathy
- p.Lys169Arg Single submitter Cardiovascular phenotype
- p.Lys172Asn Single submitter
- p.Lys179Arg Single submitter RASopathy
- p.Lys88fs Single submitter
- p.Met111Thr Single submitter RASopathy ⚠
- p.Met170Ile Single submitter RASopathy
- p.Met188Ile Single submitter RASopathy
- p.Met188Thr Single submitter RASopathy
- p.Met188Val Single submitter RASopathy
- p.Phe141Tyr Single submitter hereditary breast carcinoma ⚠
- p.Phe90Tyr Single submitter RASopathy ⚠
- p.Pro140Ser Single submitter RASopathy ⚠
- p.Ser17Thr Single submitter vascular malformation ⚠
- p.Ser65Thr Single submitter Cardiovascular phenotype ⚠
- p.Thr124Ile Single submitter ⚠
- p.Thr127Arg Single submitter ⚠
- p.Thr148Arg Single submitter RASopathy ⚠
- p.Thr158Arg Single submitter RASopathy
- p.Thr183Ala Single submitter RASopathy
- p.Thr183Arg Single submitter RASopathy
- p.Thr183Lys Single submitter RASopathy
- p.Thr20Ala Single submitter cardiofaciocutaneous syndrome 2 ⚠
- p.Thr2Pro Single submitter Cardiovascular phenotype ⚠
- p.Thr50Ala Single submitter RASopathy ⚠
- p.Thr50Ser Single submitter ⚠
- p.Thr87Ala Single submitter RASopathy ⚠
- p.Tyr40Cys Single submitter RASopathy ⚠
- p.Tyr64Asn Single submitter Inborn genetic diseases ⚠
- p.Tyr64Ser Single submitter Inborn genetic diseases ⚠
- p.Val103Phe Single submitter RASopathy ⚠
- p.Val109Ala Single submitter RASopathy ⚠
- p.Val109Glu Single submitter Cardiovascular phenotype ⚠
- p.Val109Ile Single submitter RASopathy ⚠
- p.Val125Ile Single submitter RASopathy ⚠
- p.Val160Gly Single submitter
- p.Val186Ile Single submitter RASopathy
- p.Val29Met Single submitter Noonan syndrome 3 ⚠
- p.Val81Ala Single submitter RASopathy ⚠
- p.Val9Ala Single submitter Cardiovascular phenotype ⚠
- c.111+11T>C No assertion criteria prostate cancer, hereditary, 1
- c.111+1G>C No assertion criteria prostate cancer, hereditary, 1
- c.111+24A>G No assertion criteria prostate cancer, hereditary, 1
- c.111+25T>C No assertion criteria prostate cancer, hereditary, 1
- c.111+28C>T No assertion criteria prostate cancer, hereditary, 1
- c.111+30G>T No assertion criteria prostate cancer, hereditary, 1
- c.111+50T>A No assertion criteria prostate cancer, hereditary, 1
- c.111+53A>G No assertion criteria prostate cancer, hereditary, 1
- c.111+6T>C No assertion criteria prostate cancer, hereditary, 1
- c.111+8T>C No assertion criteria prostate cancer, hereditary, 1
- c.291-50A>G No assertion criteria squamous cell lung carcinoma
- c.-10C>G No assertion criteria prostate cancer, hereditary, 1
- c.-11-10T>G No assertion criteria prostate cancer, hereditary, 1
- c.-11-12T>A No assertion criteria prostate cancer, hereditary, 1
- c.-11-12T>G No assertion criteria prostate cancer, hereditary, 1
- c.-11-1G>C No assertion criteria prostate cancer, hereditary, 1
- c.-11-21T>G No assertion criteria prostate cancer, hereditary, 1
- c.-11-2A>C No assertion criteria prostate cancer, hereditary, 1
- c.-11-2A>T No assertion criteria prostate cancer, hereditary, 1
- c.-11-36C>T No assertion criteria prostate cancer, hereditary, 1
- c.-11-4T>A No assertion criteria prostate cancer, hereditary, 1
- c.-11-51del No assertion criteria prostate cancer, hereditary, 1
- c.-11-7T>A No assertion criteria prostate cancer, hereditary, 1
- c.-11-8_-11-7insC No assertion criteria prostate cancer, hereditary, 1
- c.-11-8A>C No assertion criteria prostate cancer, hereditary, 1
- c.-11delG No assertion criteria prostate cancer, hereditary, 1
- c.-11G>A No assertion criteria prostate cancer, hereditary, 1
- c.-148_-137del No assertion criteria
- c.-6C>T No assertion criteria prostate cancer, hereditary, 1
- p.Ala11= No assertion criteria prostate cancer, hereditary, 1
- p.Ala11fs No assertion criteria prostate cancer, hereditary, 1
- p.Ala11Ser No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Asn26Thr No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Asp30Glu No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Asp33= No assertion criteria prostate cancer, hereditary, 1
- p.Gln22Pro No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Gln25_Asn26del No assertion criteria
- p.Gln25Arg No assertion criteria ⚠
- p.Gln25Leu No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Glu31Ter No assertion criteria prostate cancer, hereditary, 1
- p.Glu37fs No assertion criteria prostate cancer, hereditary, 1
- p.Glu37Ter No assertion criteria prostate cancer, hereditary, 1
- p.Glu63Lys No assertion criteria teratoma ⚠
- p.Gly10= No assertion criteria prostate cancer, hereditary, 1
- p.Gly10del No assertion criteria prostate cancer, hereditary, 1
- p.Gly15= No assertion criteria
- p.Gly15Cys No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Gly60= No assertion criteria
- p.His27Arg No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.His27Leu No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Ile21Lys No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Ile36Lys No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Ile55Ser No assertion criteria Noonan syndrome ⚠
- p.Leu6= No assertion criteria
- p.Leu6Phe No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Lys182del No assertion criteria Noonan syndrome 3
- p.Lys5Ter No assertion criteria prostate cancer, hereditary, 1
- p.Met1* No assertion criteria prostate cancer, hereditary, 1
- p.Phe28fs No assertion criteria prostate cancer, hereditary, 1
- p.Phe28Leu No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Ser17Ile No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Thr2= No assertion criteria prostate cancer, hereditary, 1
- p.Thr2fs No assertion criteria prostate cancer, hereditary, 1
- p.Thr2Ser No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Tyr32Ser No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Tyr4Asn No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Tyr4fs No assertion criteria prostate cancer, hereditary, 1
- p.Tyr4Phe No assertion criteria prostate cancer, hereditary, 1 ⚠
- p.Tyr4Ter No assertion criteria prostate cancer, hereditary, 1
- p.Val14= No assertion criteria prostate cancer, hereditary, 1
- p.Val7Met No assertion criteria ⚠
- p.Val8fs No assertion criteria prostate cancer, hereditary, 1
- p.Val8Ile No assertion criteria ⚠
- p.Val9= No assertion criteria prostate cancer, hereditary, 1
- p.Val9_Gly10insLeu No assertion criteria prostate cancer, hereditary, 1
- p.Val9fs No assertion criteria prostate cancer, hereditary, 1